Abstract
In a factory population the occurrence of reactions to tetanus toxoid was recorded after 6740 injections. The incidence of general reactions was 0·3% and of local reactions 2·6%. The local reaction rate to the first injection of the basic immunization course was 0·9%, to the second injection 2·7%, and to the third injection 7·4%. To booster injections the rate was 1·6%. The local reaction rate was appreciably higher in women than in men — 14·4% and 5·7% respectively in the case of the third injection — and the incidence among women increased with age.
Tetanus vaccine containing 10 Lf of toxoid caused fewer reactions than one containing 20 Lf, but a reduction in the content of aluminium adjuvant did not affect the reaction rate.
Almost all reactors were found to have a satisfactory serum antitoxin concentration at the time of the reaction or developed a satisfactory immunity within 1-6 months.
Skin tests were made in 32 hypersensitive patients. Neither the diluent, thiomersal preservative, nor the culture medium appeared to be responsible for hypersensitivity. The degree of hypersensitivity elicited by a special highly purified toxoid was only very slightly less than that elicited by the commercially pure toxoid. It is suggested that reactions are largely due to the toxoid antigen itself rather than to impurities or other components of the vaccine.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- FISEK N. H., MUELLER J. H., MILLER P. A. Muscle extractives in the production of tetanus toxin. J Bacteriol. 1954 Mar;67(3):329–334. doi: 10.1128/jb.67.3.329-334.1954. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fardon D. F. Unusual reactions to tetanus toxoid. JAMA. 1967 Jan 9;199(2):125–126. [PubMed] [Google Scholar]
- Gross E., Bartels H., Körner L., Kindt H. Antitoxintiter nach Tetanus-Immunisierung. Verlauf bei Verwendung von Absorbat-und Fluid-Impfstoffen für die dritte Injektion. Munch Med Wochenschr. 1970 May 1;112(18):846–850. [PubMed] [Google Scholar]
- Hansson H., Möller H. Cutaneous reactions to merthiolate and their relationship to vaccination with tetanus toxoid. Acta Allergol. 1971 Apr;26(2):150–156. doi: 10.1111/j.1398-9995.1971.tb01291.x. [DOI] [PubMed] [Google Scholar]
- Hansson H., Möller H. Intracutaneous test reactions to tuberculin containing merthiolate as a preservative. Scand J Infect Dis. 1971;3(2):169–172. doi: 10.3109/inf.1971.3.issue-2.12. [DOI] [PubMed] [Google Scholar]
- Peebles T. C., Levine L., Eldred M. C., Edsall G. Tetanus-toxoid emergency boosters: a reappraisal. N Engl J Med. 1969 Mar 13;280(11):575–581. doi: 10.1056/NEJM196903132801102. [DOI] [PubMed] [Google Scholar]
- Reisman R. E. Delayed hypersensitivity to merthiolate preservative. J Allergy. 1969 Apr;43(4):245–248. doi: 10.1016/0021-8707(69)90067-7. [DOI] [PubMed] [Google Scholar]
- Relihan M. Reactions to tetanus toxoid. J Ir Med Assoc. 1969 Dec;62(390):430–434. [PubMed] [Google Scholar]
- Scheibel I., Bentzon M. W., Christensen P. E., Biering A. Duration of immunity to diphtheria and tetanus after active immunization. Acta Pathol Microbiol Scand. 1966;67(3):380–392. doi: 10.1111/apm.1966.67.3.380. [DOI] [PubMed] [Google Scholar]
- TRINCA J. C. ACTIVE TETANUS IMMUNIZATION: EFFECT OF A REDUCED REINFORCING DOSE OF ADSORBED TOXOID ON THE PARTLY IMMUNIZED REACTIVE PATIENT. Med J Aust. 1963 Sep 7;2:389–392. doi: 10.5694/j.1326-5377.1963.tb24994.x. [DOI] [PubMed] [Google Scholar]
- White W. G., Barnes G. M., Griffith A. H., Gall D., Barker E., Smith J. W. Duration of immunity after active immunisation against tetanus. Lancet. 1969 Jul 12;2(7611):95–96. doi: 10.1016/s0140-6736(69)92404-0. [DOI] [PubMed] [Google Scholar]
- Yeager L. B. Symposium on immunization. Problems of immunizing college-age adults. Arch Environ Health. 1967 Oct;15(4):502–507. doi: 10.1080/00039896.1967.10664955. [DOI] [PubMed] [Google Scholar]